2022•Unpublished venueRequires access

“Intranasal Delivery”

Noriyasu Kamei, Mariko Takeda‐Morishita

Open publisher page 0 citations

Abstract

In this chapter, we describe the applicability of cell-penetrating peptides (CPPs) to enhance nasal absorption to the systemic circulation and the nose-to-brain delivery of biologics. The intranasal coadministration with amphipathic CPP, penetratin, can significantly increase the systemic absorption of peptides and proteins such as insulin and interferon, and interestingly it has also the potential to deliver drugs to the brain, which is the most difficult therapeutic target in the body. Importantly, noninvasive intranasal administration can be a patient-friendly route compared to invasive administration routes such as intravenous and subcutaneous injections. Thus, CPPs can be useful tools for enhancing the nasal permeation of various therapeutic modalities, thereby increasing their clinical value.

About this research paper

What this paper is about

In this chapter, we describe the applicability of cell-penetrating peptides (CPPs) to enhance nasal absorption to the systemic circulation and the nose-to-brain delivery of biologics. The intranasal coadministration with amphipathic CPP, penetratin, can significantly increase the systemic absorption of peptides and proteins such as insulin and interferon, and interestingly it has also the potential to deliver drugs to the brain, which is the most difficult therapeutic target in the body. Importantly, noninvasive intranasal administration can be a patient-friendly route compared to invasive administration routes such as intravenous and subcutaneous injections. Thus, CPPs can be useful tools for enhancing the nasal permeation of various therapeutic modalities, thereby increasing their clinical value.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In this chapter, we describe the applicability of cell-penetrating peptides (CPPs) to enhance nasal absorption to the systemic circulation and the nose-to-brain delivery of biologics. The intranasal coadministration with amphipathic CPP, penetratin, can significantly increase the systemic absorption of peptides and proteins such as insulin and interferon, and interestingly it has also the potential to deliver drugs to the brain, which is the most difficult therapeutic target in the body. Importantly, noninvasive intranasal administration can be a patient-friendly route compared to invasive administration routes such as intravenous and subcutaneous injections. Thus, CPPs can be useful tools for enhancing the nasal permeation of various therapeutic modalities, thereby increasing their clinical value.

Key concepts: Nasal administration, Systemic circulation, Medicine, Pharmacology, Systemic administration, Absorption (acoustics), Drug delivery, Route of administration

Related papers

Back to paper searchBrowse research topicsOriginal source
“Intranasal Delivery” — Research Paper | ScholarLens